Sale

Ascites Market

Global Ascites Market Share, Size, Analysis, Report, Demand, Growth, Forecast: By Treatment: Medicinal Therapy, Surgery, Paracentesis, Others; By Diagnosis: Ultrasound, CT Scan, MRI, Blood Test, Laparoscopy, Angiography, Others; By Route of Administration: Oral, Parenteral, Others; By End User; Regional Analysis; Supplier Landscape; 2024-2032

Global Ascites Market Outlook

The global ascites market size attained a value of USD 2.16 billion in 2023. The major drivers of the industry, such as the increasing prevalence of the disease, rising disposable incomes, growing health consciousness, rapid urbanisation, and growing R&D activities, are expected to aid the market growth. The market is anticipated to grow at a CAGR of 4.30% during the forecast period of 2024-2032 to attain a value of USD 3.15 billion by 2032.

 

Global Ascites Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The North American and the European Market for Ascites to Be Aided by the Advancements in Healthcare Industry

North America and Europe are expected to be the key regional markets for ascites treatment. This dominance can be correlated to the highly developed healthcare infrastructure and higher awareness about ascites and its subsequent diagnosis and treatment methods. The availability of skilled and knowledgeable healthcare professionals in developed countries is also aiding the growth in these regions.

The Asia Pacific market is projected to witness a swift growth owing to the rising literacy rate and improving economic conditions. Rapid development in the healthcare industry in countries, such as China, India, and Japan, are aiding the Asia Pacific market growth. The ascites industry in Latin American nations, such as Brazil, Argentina, and Mexico, is anticipated to have a steady growth owing to the availability of advanced healthcare facilities.

 

Ascites: Market Segmentation

Accumulation of fluid in the peritoneal cavity (i.e., the space between the lining of abdominal organs and abdomen) is known as ascites. It is often caused by scarring of the liver due to cirrhosis. Some of the other causes of ascites may include liver damage, hepatitis B or C, and alcohol consumption. If not treated appropriately, ascites could lead to kidney failure, peritonitis, blood sepsis, and ultimately death.

 

Global Ascites Market By Type

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the market can be classified into:

  • Transudative
  • Exudative

By diagnosis, the market is segmented into:

  • Angiography
  • CT Scan
  • Laparoscopy
  • Ultrasound
  • Others

Based on treatment, the market is categorised into:

  • Medicinal Therapy
  • Diuretics
  • Antibiotics 
  • Liver Transplantation
  • Paracentesis
  • Others

The EMR report looks into the regional markets of ascites like North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa.

 

Global Ascites Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Prevalence of the Liver Cirrhosis to Bolster the Market Growth of Ascites

The global market for ascites is being driven by the growing awareness about the disease. Ascites are one of the main complications of liver cirrhosis. The rising prevalence of liver cirrhosis across the globe due to the increasing consumption of alcohol is driving the market. The increasing healthcare activities and campaigns regarding the necessity to address ascites are aiding the market. Moreover, the rising investments in research and development projects are adding to the market growth. Highly developed healthcare infrastructure and the availability of skilled professionals are aiding the market in mature nations. On the other hand, the market in emerging nations is showing great potential owing to the improving economic conditions and rising literacy rates. Furthermore, rising disposable incomes and increasing awareness about the available treatment methods are expected to provide an impetus for the market growth in the forecast period.

 

Key Industry Players in the Global Ascites Market

The report presents a detailed analysis of the following key players in the global ascites market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Becton, Dickinson, and Company
  • BioVie Inc.
  • Sequana Medical NV
  • Sanofi Inc.
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Treatment
  • Diagnosis
  • Route of Administration
  • End User
  • Region
Breakup by Treatment
  • Medicinal Therapy
  • Surgery
  • Paracentesis
  • Others
Breakup by Diagnosis
  • Ultrasound
  • CT Scan
  • MRI
  • Blood Test
  • Laparoscopy
  • Angiography
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Others
Breakup by End User
  • Hospitals & Clinics
  • Research and Academic Laboratories
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Becton, Dickinson and Company
  • BioVie Inc.
  • Sequana Medical NV
  • Sanofi Inc.
  • F. Hoffmann-La Roche Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • WOCKHARDT

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Ascites Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Ascites Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Ascites Epidemiology (2016-2031)
    5.3    Europe Ascites Epidemiology (2016-2031)
    5.4    Asia-Pacific Ascites Epidemiology (2016-2031)
    5.5    Latin America Ascites Epidemiology (2016-2031)
    5.6    Middle East & Africa Ascites Epidemiology (2016-2031)
6    Global Ascites Market Overview 
    6.1    Global Ascites Market Historical Value (2017-2023)
    6.2    Global Ascites Market Forecast Value (2024-2032)
7    Global Ascites Market Landscape
    7.1    Ascites: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Ascites: Product Landscape
        7.2.1    Analysis by Treatment
        7.2.2    Analysis by Diagnosis
        7.2.3    Analysis by Route of Administration 
        7.2.4    Analysis by End User
8    Ascites Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Ascites Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Ascites Market Segmentation
    11.1    Global Ascites Market by Treatment
        11.1.1    Market Overview
        11.1.2    Medicinal Therapy
            11.1.2.1    Diuretics
            11.1.2.2    Antibiotics
        11.1.3    Surgery
        11.1.4    Paracentesis
        11.1.5    Others
    11.2    Global Ascites Market by Diagnosis
        11.2.1    Market Overview
        11.2.2    Ultrasound
        11.2.3    CT Scan
        11.2.4    MRI
        11.2.5    Blood Test
        11.2.6    Laparoscopy
        11.2.7    Angiography
        11.2.8    Others
    11.3    Global Ascites Market by Route of Administration
        11.3.1    Market Overview
        11.3.2    Oral
        11.3.3    Parenteral
        11.3.4    Others
    11.4    Global Ascites Market by End User
        11.4.1    Market Overview
        11.4.2    Hospitals & Clinics
        11.4.3    Research and Academic Laboratories
        11.4.4    Others
    11.5    Global Ascites Market by Region
        11.5.1    Market Overview
        11.5.2    North America
        11.5.3    Europe 
        11.5.4    Asia Pacific
        11.5.5    Latin America
        11.5.6    Middle East and Africa
12    North America Ascites Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Ascites Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Ascites Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Ascites Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Ascites Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    Becton, Dickinson and Company
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    BioVie Inc.
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Sequana Medical NV
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4    Sanofi Inc.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    F. Hoffmann-La Roche Ltd.
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Teva Pharmaceutical Industries Ltd.
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    Novartis AG
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Sun Pharmaceutical Industries Ltd.
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Merck & Co., Inc.
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    WOCKHARDT
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
24    Ascites - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global market for ascites reached a value of USD 2.16 billion.

The market is anticipated to grow at a CAGR of 4.30% during the forecast period of 2024-2032 to reach a value of USD 3.15 billion by 2032.

The major drivers of the industry, such as the increasing prevalence of the disease, rising disposable incomes, growing health consciousness, rapid urbanisation, and growing R&D activities, are expected to aid the market growth.

The key trend in the market is the growing healthcare investments by governmental and non-governmental players.

The major regional markets for ascites are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The major types of ascites in the market are transudative and exudative.

The leading treatment types in the market are medicinal therapy, liver transplantation, and paracentesis, among others.

The major diagnosis methods in the market are angiography, CT scan, laparoscopy, ultrasound, and others.

The key players in the market include Becton, Dickinson and Company, BioVie Inc., Sequana Medical NV, and Sanofi Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER